High-resolution HLA genotyping in inclusion body myositis refines 8.1 ancestral haplotype association to DRB1*03:01:01 and highlights pathogenic role of arginine-74 of DRβ1 chain
Authors:
Open Access
- 2 December 2023
- journal article
- research article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 142, 103150
Abstract
No abstract availableKeywords
Funding Information
- Western Australian Future Health and Innovation Fund, Government of Western Australia
- Murdoch University
- Perron Institute for Neurological and Translational Science
- Spinnaker Health Research Foundation
This publication has 44 references indexed in Scilit:
- A Novel Variant Marking HLA-DP Expression Levels Predicts Recovery from Hepatitis B Virus InfectionJournal of Virology, 2012
- Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritisNature Genetics, 2012
- Towards a systems understanding of MHC class I and MHC class II antigen presentationNature Reviews Immunology, 2011
- Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complexJournal of Neuroimmunology, 2011
- Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditisProceedings of the National Academy of Sciences, 2010
- Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotypeNeuromuscular Disorders, 2009
- Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory MyopathiesMedicine, 2005
- Arginine at position 74 of the HLA-DR β1 chain is associated with Graves' diseaseGenes & Immunity, 2004
- Ancestral haplotypes: conserved population MHC haplotypesHuman Immunology, 1992
- Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositisAnnals of Neurology, 1984